Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 22;10(5):e26875.
doi: 10.1016/j.heliyon.2024.e26875. eCollection 2024 Mar 15.

Magnetic anchoring device assisted-laparoscopic sleeve gastrectomy versus conventional laparoscopic sleeve gastrectomy: A retrospective cohort study

Affiliations

Magnetic anchoring device assisted-laparoscopic sleeve gastrectomy versus conventional laparoscopic sleeve gastrectomy: A retrospective cohort study

Runkun Liu et al. Heliyon. .

Abstract

Background: Bariatric surgeries, including the sleeve gastrectomy, have been recognized as the most effectively treatment strategy for severe obesity. Magnetic devices have been successfully used in bariatric surgeries. Here, we intended to evaluate the safety and efficiency of magnetic anchoring device assisted-laparoscopic sleeve gastrectomy (MLSG), and to make a comparison of the short-term results between conventional laparoscopic sleeve gastrectomy (CLSG) and MLSG.

Methods: The retrospective cohort study was carried out by analyzing and summarizing the data from a database of routinely collected data. The cohort included the patients who underwent either CLSG (n = 120) or MLSG (n = 115) at a single center between January 2018 and December 2020 with a two-year follow-up. The effects of these two surgeries on the weight loss, resolution of comorbidities and quality of life (QOL) were analyzed.

Results: The two groups were similar in gender, age, body mass index, abdominal girth, as well as the type and proportion of comorbidities. And the cases in MLSG group had a markedly shorter time of operation (MLSG, 72.59 min vs. CLSG, 76.67 min; P = 0.003). Length of stay in hospital was significantly shorter in the MLSG group than that in the CLSG group (MLSG, 5.59 days vs. CLSG, 5.96 days; P = 0.016). Neither fatal event nor conversion to open surgery happened among all cases. There were no differences in terms of the postoperative complications between the two groups. Magnetic device-related mild hepatic lacerations occurred and were handled by hemostatic treatments in 3 cases. The QOL of patients in MLSG was better at 6-month after surgery, but there was no significant difference between the two groups at 1-year or 2-year after surgery.

Conclusion: Both MLSG and CLSG prove safe and effective, and the patients underwent MLSG have a shorter length of stay in hospital, and a better QOL during 6 months after surgery.

Keywords: Laparoscopic sleeve gastrectomy; Magnetic anchoring device; Obesity; Quality of life; Retrospective study.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Quality of life before and after surgery. The SF-36 questionnaire was applied to value the quality of life (QOL) of the patients in CLSG group and MLSG group before and after surgery. (A), (B), (C) represented mental health score, physical health score and total score respectively. *P < 0.05, **P < 0.01.
None
Supplemental Fig.1 The magnetic retraction system for surgical field exposure, and intra-operative picture of MLSG.

Similar articles

References

    1. Rosenbaum M., Foster G. Differential mechanisms affecting weight loss and weight loss maintenance. Nat. Metab. 2023;5(8):1266–1274. - PubMed
    1. Morawietz H., et al. Cross-talk of NADPH Oxidases and Inflammation in obesity. Antioxidants. 2023;12(8) - PMC - PubMed
    1. Harborg S., et al. New horizons: epidemiology of obesity, diabetes mellitus, and cancer prognosis. J. Clin. Endocrinol. Metab. 2023 dgad450. - PubMed
    1. Bashir B., et al. Microvascular complications of obesity and diabetes-Role of bariatric surgery. Obes. Rev. 2023 - PubMed
    1. Vick L.V., et al. Multifaceted effects of obesity on cancer immunotherapies: bridging preclinical models and clinical data. Semin. Cancer Biol. 2023;95:88–102. - PMC - PubMed

LinkOut - more resources